2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Activation of cannabinoid type 1 receptor (CB1) modulates oligodendroglial process branching complexity in rat hippocampal cultures stimulated by olfactory ensheathing glia-conditioned medium

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The endocannabinoid system (ECS) refers to a complex cell-signaling system highly conserved among species formed by numerous receptors, lipid mediators (endocannabinoids) and synthetic and degradative enzymes. It is widely distributed throughout the body including the CNS, where it participates in synaptic signaling, plasticity and neurodevelopment. Besides, the olfactory ensheathing glia (OEG) present in the olfactory system is also known to play an important role in the promotion of axonal growth and/or myelination. Therefore, both OEG and the ECS promote neurogenesis and oligodendrogenesis in the CNS. Here, we investigated if the ECS is expressed in cultured OEG, by assessing the main markers of the ECS through immunofluorescence, western blotting and qRT-PCR and quantifying the content of endocannabinoids in the conditioned medium of these cells. After that, we investigated whether the production and release of endocannabinoids regulate the differentiation of oligodendrocytes co-cultured with hippocampal neurons, through Sholl analysis in oligodendrocytes expressing O4 and MBP markers. Additionally, we evaluated through western blotting the modulation of downstream pathways such as PI3K/Akt/mTOR and ERK/MAPK, being known to be involved in the proliferation and differentiation of oligodendrocytes and activated by CB1, which is the major endocannabinoid responsive receptor in the brain. Our data show that OEG expresses key genes of the ECS, including the CB1 receptor, FAAH and MAGL. Besides, we were able to identify AEA, 2-AG and AEA related mediators palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), in the conditioned medium of OEG cultures. These cultures were also treated with URB597 10-9 M, a FAAH selective inhibitor, or JZL184 10-9 M, a MAGL selective inhibitor, which led to the increase in the concentrations of OEA and 2-AG in the conditioned medium. Moreover, we found that the addition of OEG conditioned medium (OEGCM) enhanced the complexity of oligodendrocyte process branching in hippocampal mixed cell cultures and that this effect was inhibited by AM251 10-6 M, a CB1 receptor antagonist. However, treatment with the conditioned medium enriched with OEA or 2-AG did not alter the process branching complexity of premyelinating oligodendrocytes, while decreased the branching complexity in mature oligodendrocytes. We also observed no change in the phosphorylation of Akt and ERK 44/42 in any of the conditions used. In conclusion, our data show that the ECS modulates the number and maturation of oligodendrocytes in hippocampal mixed cell cultures.

          Related collections

          Most cited references69

          • Record: found
          • Abstract: not found
          • Article: not found

          Protein measurement with the Folin phenol reagent.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Dendritic organization in the neurons of the visual and motor cortices of the cat.

            D SHOLL (1953)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

              Endogenous neuromodulatory molecules are commonly coupled to specific metabolic enzymes to ensure rapid signal inactivation. Thus, acetylcholine is hydrolysed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases. Previously, we reported the structure and sleep-inducing properties of cis-9-octadecenamide, a lipid isolated from the cerebrospinal fluid of sleep-deprived cats. cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results). We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid. We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes. We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling molecules, the fatty-acid amides. Therefore we will hereafter refer to oleamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cell Neurosci
                Front Cell Neurosci
                Front. Cell. Neurosci.
                Frontiers in Cellular Neuroscience
                Frontiers Media S.A.
                1662-5102
                17 April 2023
                2023
                : 17
                : 1134130
                Affiliations
                [1] 1Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil
                [2] 2Laboratório de Neurobiologia Comparativa e do Desenvolvimento, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil
                [3] 3Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, CNR , Pozzuoli, Italy
                [4] 4Laboratório de Doenças Neurodegenerativas, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil
                [5] 5Laboratório de Biomembranas, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil
                [6] 6Laboratório de Agregação de Proteínas e Amiloidoses, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil
                [7] 7Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis, Laval University , Quebec, QC, Canada
                [8] 8Experimental Therapeutics and Molecular Imaging Laboratory, Massachusetts General Hospital , Boston, MA, United States
                [9] 9Neuroscience Program, Harvard Medical School , Boston, MA, United States
                Author notes

                Edited by: Vinicius Toledo Ribas, Federal University of Minas Gerais, Brazil

                Reviewed by: Victor Rodrigues Santos, Federal University of Minas Gerais, Brazil; Amin Derouiche, Goethe University Frankfurt, Germany

                *Correspondence: Luzia S. Sampaio, sampaio.lu@ 123456biof.ufrj.br

                These authors have contributed equally to this work and share first authorship

                These authors share last authorship

                This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience

                Article
                10.3389/fncel.2023.1134130
                10150319
                8e3a2e3d-d761-41b2-ab99-d4e3e4941120
                Copyright © 2023 Paes-Colli, Trindade, Vitorino, Piscitelli, Iannotti, Campos, Isaac, de Aguiar, Allodi, de Mello, Einicker-Lamas, de Siqueira-Santos, Di Marzo, Tannous, Carvalho, De Melo Reis and Sampaio.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 29 December 2022
                : 16 March 2023
                Page count
                Figures: 10, Tables: 2, Equations: 0, References: 69, Pages: 17, Words: 10806
                Funding
                This study was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). LS was supported by FAPERJ, grant no. E-26/202.997/2019. RD was supported by FAPERJ, grant nos. E-26/202.668/2018 and E-26/010.002215/2019; Grant nos. 426342/2018-6 and 312157/2016-9; INCT-INNT (National Institute for Translational Neuroscience).
                Categories
                Neuroscience
                Original Research

                Neurosciences
                cannabinoid receptor 1,oligodendrocyte,olfactory ensheathing glia,endocannabinoids,myelin basic protein (mbp),hippocampus

                Comments

                Comment on this article